Consensus on the management of inflammatory bowel disease in China in 2007.
about
The th17/treg immune balance in ulcerative colitis patients with two different chinese syndromes: dampness-heat in large intestine and spleen and kidney yang deficiency syndromeConfluent granulomas and ulcers lined by epithelioid histiocytes: new ideal method for differentiation of ITB and CD? A meta analysisHealth-related quality of life in Chinese patients with mild and moderately active ulcerative colitisThe Th17/Treg Immune Imbalance in Ulcerative Colitis Disease in a Chinese Han Population.Multicenter case-control study of the risk factors for ulcerative colitis in China.Helicobacter pylori and Crohn's disease: a retrospective single-center study from ChinaDiagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul.miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism.Epidemiology of lower gastrointestinal bleeding in China: single-center series and systematic analysis of Chinese literature with 53,951 patients.Development and Validation of a Novel Prediction Model for Differential Diagnosis Between Crohn's Disease and Intestinal Tuberculosis.Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.Risk factors that predict the requirement of aggressive therapy among Chinese patients with Crohn's disease.Inflammatory bowel disease in the 21(st) century in China: turning challenges into opportunities.Asian Perspectives on Diagnostic and Therapeutic Strategies in Inflammatory Bowel Disease: Report and Analysis of a Survey with Questionnaires.Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: A prospective observational study
P2860
Q35177977-65BAC6B7-AC44-48B7-9A43-091EF7AAE8C8Q35315326-D9B459AC-79DB-4B76-BD18-A00D35238531Q35542672-68BDADC4-20D6-4D32-9BE1-DA14007AAE11Q36605404-B6B5DFC6-D08F-484E-B832-9A6E2D642F62Q36715099-C41CC59E-0833-437A-9037-27C1F2B6E039Q37050515-A3B61435-5196-42B2-89C0-8D80B402AD2EQ37095800-F6E520D9-1D15-428E-A674-DABD6938DEF4Q37572580-669331F3-9FB4-491D-8213-00FB1FC4A35EQ37810316-91C628A8-459D-430C-A132-1A29F858F517Q40133089-15983B56-B8A1-449C-98AF-7C3EFEE35B5BQ42775168-2B10DC80-0B2A-4ABA-9ACA-C36EC826D55AQ44429482-5ADA2008-DAA5-4FFA-822E-54FD890D7512Q46087755-3EAD5690-A3FF-4E77-9E5A-F933B5B3B530Q48022586-30B97BDD-9E96-4F65-B55C-4421121A2D11Q58706715-8CD90E02-A99A-49CD-90B6-D74776BFC29D
P2860
Consensus on the management of inflammatory bowel disease in China in 2007.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Consensus on the management of inflammatory bowel disease in China in 2007.
@en
Consensus on the management of inflammatory bowel disease in China in 2007.
@nl
type
label
Consensus on the management of inflammatory bowel disease in China in 2007.
@en
Consensus on the management of inflammatory bowel disease in China in 2007.
@nl
prefLabel
Consensus on the management of inflammatory bowel disease in China in 2007.
@en
Consensus on the management of inflammatory bowel disease in China in 2007.
@nl
P2093
P2860
P1476
Consensus on the management of inflammatory bowel disease in China in 2007.
@en
P2093
CHINESE COOPERATIVE GROUP FOR THE STUDY ON IBD
CHINESE SOCIETY OF GASTROENTEROLOGY
Jia Ju Zheng
Jia Ming Qian
Pin Jin Hu
Qin Ouyang
Ren Wei Hu
P2860
P356
10.1111/J.1443-9573.2007.00320.X
P577
2008-02-01T00:00:00Z